$49.33
0.310.63%
Pre-Market: 5:19 AM EDT
15 minutes delayed
Bristol-Myers Squibb reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Bristol-Myers Squibb using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-26 | $2.07 | $1.63 | 27.0 % |
Mar 2024 | 2024-04-25 | $-4.40 | $-4.44 | 0.90 % |
Dec 2023 | 2024-02-02 | $1.70 | $1.53 | 11.1 % |
Sep 2023 | 2023-10-26 | $2.00 | $1.76 | 13.6 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-26 | $12.20B | $11.55B | 5.64 % |
Mar 2024 | 2024-04-25 | $11.87B | $11.46B | 3.53 % |
Dec 2023 | 2024-02-02 | $11.48B | $11.19B | 2.55 % |
Sep 2023 | 2023-10-26 | $10.97B | $10.97B | -0.04 % |
Bristol-Myers Squibb (BMY) is scheduled to report earnings on October 31, 2024. The last reported earnings were for reported on July 26, 2024 for Q2.
The Actual EPS was $2.07, which beat the estimate of $1.63.
The Actual Revenue was $12.2B, which beat the estimate of $11.6B.
Browse earnings estimates, EPS, and revenue on all stocks.